Related Experiment Videos

Ampicillin-resistant Haemophilus influenzae. 1. Incidence, mechanism, and detection

Postgraduate Medicine
|January 1, 1982
PubMed

Insights

Ampicillin resistance in Haemophilus influenzae is rising, with rates varying by location. Most resistant strains produce beta-lactamase, an enzyme encoded on plasmids, necessitating awareness for effective treatment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Haemophilus influenzae was historically susceptible to ampicillin.
  • Increasing ampicillin resistance in H. influenzae is a growing concern.
  • Reported resistance rates range from 6.6% to 48% across different settings.

Purpose of the Study:

  • To highlight the increasing ampicillin resistance in Haemophilus influenzae.
  • To inform healthcare professionals about the prevalence and mechanisms of resistance.
  • To emphasize the importance of local resistance data for guiding treatment decisions.

Main Methods:

  • The abstract does not detail specific experimental methods.
  • It summarizes existing knowledge and reported resistance rates.
  • Focuses on the mechanism of resistance (beta-lactamase production).

Main Results:

  • Ampicillin resistance in H. influenzae is increasing globally.
  • The primary mechanism of resistance is beta-lactamase production.
  • Resistance rates vary significantly between institutions and communities.

Conclusions:

  • Physicians and microbiologists must be aware of ampicillin-resistant H. influenzae strains.
  • Beta-lactamase production, mediated by plasmids, is the main cause of resistance.
  • Understanding local resistance incidence is crucial for selecting appropriate empiric therapy for infections like meningitis and otitis media.

Related Concept Videos